-
Reviewers for Journal of Dual Diagnosis J. Dual Diagn. (IF 1.231) Pub Date : 2021-01-22
(2021). Reviewers for Journal of Dual Diagnosis. Journal of Dual Diagnosis. Ahead of Print.
-
Personality Traits in Individuals with the Dual Diagnosis of Psychosis and Substance Use Disorders: A Comprehensive Review and Meta-Analysis J. Dual Diagn. (IF 1.231) Pub Date : 2021-01-06 Hyeonju Oh; Seon-Kyeong Jang; Hyeon-Seung Lee; Eun-Byeol Lee; Kee-Hong Choi
Abstract Objective Substance abuse comorbidity is highly prevalent and is linked to detrimental outcomes in individuals with psychotic disorder, but the role of personality traits as the underlying mechanism is being increasingly underscored. This study aimed to profile temperamental risks of comorbid substance use disorder in psychotic disorders by performing meta-analyses on personality trait differences
-
Journal of Dual Diagnosis: Highlights from the 2020 Issues J. Dual Diagn. (IF 1.231) Pub Date : 2021-01-05 E. Sherwood Brown
(2021). Journal of Dual Diagnosis: Highlights from the 2020 Issues. Journal of Dual Diagnosis. Ahead of Print.
-
Examining Transdiagnostic Factors among Firefighters in Relation to Trauma Exposure, Probable PTSD, and Probable Alcohol Use Disorder J. Dual Diagn. (IF 1.231) Pub Date : 2020-12-14 Antoine Lebeaut; Maya Zegel; Samuel J. Leonard; Brooke A. Bartlett; Anka A. Vujanovic
Abstract Objective Firefighters represent a distinct group of first responders that are at heightened risk of developing posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD). Assessing the role of transdiagnostic factors that underlie PTSD-AUD associations can inform specialized interventions among this population. This study included urban firefighters (N = 657) with probable PTSD-AUD
-
Prevalence of Severe Mental Illness Dual Diagnosis Among Inpatients in a Psychiatric Hospital in Malaysia J. Dual Diagn. (IF 1.231) Pub Date : 2020-12-12 Sughashini Subramaniam; Anne Yee; Amer Siddiq Bin Amer Nordin; Ahmad Qabil Bin Khalib
Abstract Objective The aim of this study was to determine the prevalence of alcohol or non-alcohol substance use dual diagnosis among inpatients with severe mental illness in a psychiatric institution in Malaysia. In addition, this study aimed to determine adverse outcomes between dual diagnosis versus single diagnosis. Methods This was a cross-sectional study conducted in the inpatient ward using
-
Cocaine and Marijuana Polysubstance Use and Cocaine Use Disorder: Investigating Mediated Effects through Patterns of Cocaine Use J. Dual Diagn. (IF 1.231) Pub Date : 2020-12-10 Yiyang Liu; JeeWon Cheong; Barry Setlow; Linda B. Cottler
Abstract Objectives Cocaine use is on the rise and it is comorbid with marijuana use. We examined the association between lifetime cocaine + marijuana polysubstance use (CM PSU) versus cocaine only and lifetime cocaine use disorder (CocUD) and examined the potential mediation by cocaine use patterns. Methods A total of 2,968 lifetime cocaine users were identified from the National Epidemiologic Survey
-
Associations Between Transdiagnostic Cognitive-Affective Vulnerability Factors, Negative Reinforcement Drinking Motives, and Problematic Alcohol Use among Undergraduates J. Dual Diagn. (IF 1.231) Pub Date : 2020-11-10 Sarah A. Hartmann; Alison C. McLeish
Abstract Objective Anxiety sensitivity, distress tolerance, and emotion regulation difficulties have each demonstrated significant individual associations with problematic alcohol use and negative reinforcement motives for alcohol use among college students. However, extant research has yet to examine these three factors simultaneously with regard to the possibility of differential associations with
-
Correlates of Concurrent Morbid Obesity and Tobacco Use Disorder Nationally in the Veterans Health Administration. J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-31 Walter Roberts,Robert A Rosenheck
Abstract Objective The aim of this study was to examine health, demographic, and service utilization characteristics of veterans with multimorbid tobacco use disorder (TUD) and morbid obesity compared to those with either condition alone. Methods: Health record data were extracted from the computerized patient record system of the Veterans Health Administration (VHA; October 1, 2011 to September 30
-
Gender Difference in Substance Use and Psychiatric Outcomes Among Dually Diagnosed Veterans Treated in Specialized Intensive PTSD Programs J. Dual Diagn. (IF 1.231) Pub Date : 2020-10-01 Elina A. Stefanovics; Robert A. Rosenheck
Abstract Objectives Posttraumatic stress disorder (PTSD) is a problem of growing importance among female veterans, which is especially challenging when accompanied by comorbid substance use disorder (SUD). Since women are still a small minority of Veterans Health Administration (VHA) patients, there is concern that outcomes among dually diagnosed women may be worse than among men. Method National program
-
Impairments in Executive Functioning in Patients with Comorbid Substance Use and Personality Disorders: A Systematic Review J. Dual Diagn. (IF 1.231) Pub Date : 2020-10-22 Enrique Moraleda-Barreno; María del Pilar Cáceres Pachón; Óscar M. Lozano; Pedro J. Pérez Moreno; José Andrés Lorca Marín; Fermín Fernández-Calderón; Carmen Díaz Batanero; Jesús Gómez-Bujedo
Abstract Objective The purpose of this systematic review was to examine the evidence for impaired executive functioning in patients diagnosed with a dual pathology of personality disorder (PD) and substance use disorder, and to identify whether differences exist in comparison to those with a single diagnosis. Methods: A systematic search was conducted to identify studies using measures of executive
-
Impact of Substance Use Disorder on Quality of Inpatient Mental Health Services for People With Anxiety and Depression J. Dual Diagn. (IF 1.231) Pub Date : 2020-10-13 Ryan Williams; Lorna Farquharson; Ellen Rhodes; Mary Dang; Jessica Butler; Alan Quirk; David S. Baldwin; Mike J. Crawford
Abstract Objective Substance use disorders are commonly comorbid with anxiety and depressive disorders and are associated with poor treatment outcomes. The mechanisms underlying this association remain unclear—one possibility is that patients with anxiety/depressive disorders and substance use disorders receive poorer treatment. Concerns have been raised about the quality of inpatient care received
-
Depression and Anxiety Subgroups Across Alcohol Use Disorder and Substance Use in a National Epidemiologic Study. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-10 Sasha Rudenstine,Adriana Espinosa,Anusha Kumar
Objective: The high prevalence of alcohol/substance use among individuals with psychiatric disorders elucidates the import of investigations into associations between types and severity of psychiatric symptoms and alcohol/substance use. This study examined the likelihood of alcohol use disorder and substance use among individuals with varying depression and anxiety symptoms and severity thereof. Differences
-
Comparing the Personality Traits of Patients with an Eating Disorder versus a Dual Diagnosis. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-03 Magda Rosińska,Marcela González González,Antoni Grau Touriño,María Soledad Mora Giral
Objectives: This cross-sectional study explored personality traits of individuals receiving treatment in a private clinic for an eating disorder (ED) compared to those receiving treatment for a dual diagnosis (DD; defined as an addiction to illegal drugs and/or alcohol along with a mental illness, in this case an ED). The aims of this study were to: (a) assess the personality profiles and differentiating
-
Obsessive-Compulsive Symptoms and Cannabis Misuse: The Explanatory Role of Cannabis Use Motives J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-07 Jafar Bakhshaie; Eric A. Storch; Nhan Tran; Michael J. Zvolensky
Objective The purpose of the present investigation was to examine the unique explanatory role of cannabis use motives above the effects of each other, for the relationship between obsessive-compulsive symptomatology and different aspects of cannabis misuse among young adults. The transitional years of young adulthood are characterized by new opportunities for experimentation as well as novel external
-
Colorectal Cancer Screening Patient Navigation for Patients with Mental Illness and/or Substance Use Disorder: Pilot Randomized Control Trial J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-07 Carolina Abuelo; Jeffrey M. Ashburner; Steven J. Atlas; Amy Knudsen; James Morrill; Patricia Corona; Derri Shtasel; Sanja Percac-Lima
Objective Colorectal cancer (CRC) is the second leading cause of cancer death in the US. Screening has decreased CRC mortality. However, disadvantaged patients, particularly those with mental illness or substance use disorder (SUD), are less likely to be screened. The aim of this trial was to evaluate the impact of a patient navigation program on CRC screening in patients with mental illness and/or
-
Self-Induced Vomiting and Other Impulsive Behaviors in Alcohol Use Disorder: A Cross-sectional Descriptive Study. J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-08 Cecily Murray,Martin Kidd,Karis Moxley,Gerhard P Jordaan
Abstract Objective To determine the prevalence of self-induced vomiting (SIV) in a sample of patients with Alcohol Use Disorder (AUD), and to explore whether such behavior is associated with a comorbid eating disorder psychopathology and other clinical symptomatology, such as impulsivity. Methods: This cross-sectional descriptive study was carried out at the Alcohol Rehabilitation Unit at Stikland
-
Obsessive-Compulsive Symptoms and Cannabis Misuse: The Explanatory Role of Cannabis Use Motives. J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-07 Jafar Bakhshaie,Eric A Storch,Nhan Tran,Michael J Zvolensky
Abstract Objective The purpose of the present investigation was to examine the unique explanatory role of cannabis use motives above the effects of each other, for the relationship between obsessive-compulsive symptomatology and different aspects of cannabis misuse among young adults. The transitional years of young adulthood are characterized by new opportunities for experimentation as well as novel
-
Colorectal Cancer Screening Patient Navigation for Patients with Mental Illness and/or Substance Use Disorder: Pilot Randomized Control Trial. J. Dual Diagn. (IF 1.231) Pub Date : 2020-08-07 Carolina Abuelo,Jeffrey M Ashburner,Steven J Atlas,Amy Knudsen,James Morrill,Patricia Corona,Derri Shtasel,Sanja Percac-Lima
Abstract Objective Colorectal cancer (CRC) is the second leading cause of cancer death in the US. Screening has decreased CRC mortality. However, disadvantaged patients, particularly those with mental illness or substance use disorder (SUD), are less likely to be screened. The aim of this trial was to evaluate the impact of a patient navigation program on CRC screening in patients with mental illness
-
Treatment Outcomes of a Multi-Component Mobile Health Smoking Cessation Pilot Intervention for People with Schizophrenia. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-31 Alyssa M Medenblik,Adam M Mann,Tiffany A Beaver,Eric A Dedert,Sarah M Wilson,Patrick S Calhoun,Jean C Beckham
Abstract Objective The objective of this study was to investigate the feasibility and acceptability of a multi-component mobile contingency management (CM) pilot intervention for smoking cessation for people with schizophrenia. Methods: This intervention included mobile CM (i.e., monetary compensation for bioverification of abstinence through using a phone app), cognitive behavioral therapy (CBT),
-
A Randomized and Controlled Acceptability Trial of an Internet-based Therapy among Inpatients with Co-occurring Substance Use and Other Psychiatric Disorders. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-23 Alexis S Hammond,Denis G Antoine,Maxine L Stitzer,Eric C Strain
Abstract Objectives Technology-assisted treatment (TAT) holds promise for innovative assessment, prevention, and treatment of substance use disorders (SUD). The widespread access to TAT makes it a potentially cost-effective and inventive option available for delivery in multiple settings. This study assessed acceptability of the web-based Therapeutic Education System (TES) in hospitalized dual diagnosis
-
Rhabdomyolysis, Methamphetamine, Amphetamine and MDMA Use: Associated Factors and Risks. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-09 John R Richards,Colin G Wang,Roderick W Fontenette,Rory P Stuart,Kerry F McMahon,Samuel D Turnipseed
Abstract Objective Rhabdomyolysis is associated with methamphetamine, amphetamine, and methylenedioxymethamphetamine (MA) use. The aim of this study was to determine the frequency, severity, and risk factors of rhabdomyolysis associated with MA use. Methods: We reviewed patients with an MA-positive toxicology screen with and without diagnosed rhabdomyolysis based on initial creatine kinase (CK) concentration
-
PTSD Predicts Smoking Cessation Failure in a Trauma-Exposed Population. J. Dual Diagn. (IF 1.231) Pub Date : 2020-07-09 Julciney Trindade Fortes,Fabiola Giordani Cano,Verônica Alcoforado Miranda,Hye Chung Kang,Leonardo F Fontenelle,Mauro Vitor Mendlowicz,Maria Luiza Garcia-Rosa
Abstract Objective The objective of the study was to investigate whether a diagnosis of posttraumatic stress disorder (PTSD; full or partial) or specific PTSD symptom clusters predicted failure in quitting smoking in a trauma-exposed population. Methods: Participants were 310 smokers who attempted quitting smoking, either successfully (quitters, n = 213) or not (relapsers, n = 97), who lived in slums
-
Contribution of Alcohol and Nicotine Dependence to the Prevalence of Depressed Mood in Different Ethnic Groups in The Netherlands: The HELIUS Study. J. Dual Diagn. (IF 1.231) Pub Date : 2020-06-18 Simone van Binnendijk,Jan G C van Amsterdam,Marieke B Snijder,Aart H Schene,Eske M Derks,Wim van den Brink
Objective: Ethnic minorities report different levels of drinking and smoking and higher rates of depression compared to native populations. In this study we aimed to investigate in six ethnic groups whether tobacco and alcohol use were associated with depressive symptoms, which are more prevalent in ethnic minorities. Methods: Cross-sectional data from the multi-ethnic Healthy Life in an Urban Setting
-
Cortisol as a Biomarker of Alcohol Use in Combat Veterans: A Literature Review and Framework for Future Research. J. Dual Diagn. (IF 1.231) Pub Date : 2020-06-04 Yvette Z Szabo,Tessa Breeding,Christina Hejl,Rakeshwar S Guleria,Steven M Nelson,Laura Zambrano-Vazquez
Objective: Alcohol use and alcohol use disorders (AUDs) are an increasing concern among veterans, particularly those from recent conflicts in Iraq and Afghanistan. The study of biomarkers in alcohol use and AUD has moved to enhancing the understanding of the development and maintenance of AUDs, as well as investigating its association with clinical severity and potential predictors of treatment response
-
Motives for Smoking in Those With PTSD, Depression, and No Psychiatric Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2020-05-12 Marika S Rosenblum,Jessica L Engle,Megan E Piper,Jesse T Kaye,Jessica W Cook
Objective: Approaches for effectively treating smoking in those with posttraumatic stress disorder (PTSD) and with major depressive disorder (MDD) could be improved by identifying motivational processes underlying their tobacco dependence. The goal of this study was to identify the motivational processes influencing smoking dependence among smokers with PTSD and with MDD relative to non-diagnosed controls
-
Interaction of Cannabis Use and Aging: From Molecule to Mind. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-30 Hye Bin Yoo,Jennifer DiMuzio,Francesca M Filbey
Given the aging Baby Boomer generation, changes in cannabis legislation, and the growing acknowledgment of cannabis for its therapeutic potential, it is predicted that cannabis use in the older population will escalate. It is, therefore, important to determine the interaction between the effects of cannabis and aging. The aim of this report is to describe the link between cannabis use and the aging
-
The Effectiveness of Cannabinoids in the Treatment of Posttraumatic Stress Disorder (PTSD): A Systematic Review. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-03 C Hindocha,J Cousijn,M Rall,M A P Bloomfield
Objectives: Posttraumatic stress disorder (PTSD) is a potentially debilitating mental health problem. There has been a recent surge of interest regarding the use of cannabinoids in the treatment of PTSD. We therefore sought to systematically review and assess the quality of the clinical evidence of the effectiveness of cannabinoids for the treatment of PTSD. Method: We included all studies published
-
Cannabinoid Receptor Type 1 and Its Role as an Analgesic: An Opioid Alternative? J. Dual Diagn. (IF 1.231) Pub Date : 2019-10-09 Amber L Milligan,Thomas A Szabo-Pardi,Michael D Burton
Understanding how the body regulates pain is fundamental to develop rational strategies to combat the growing prevalence of chronic pain states, opioid dependency, and the increased financial burden to the medical care system. Pain is the most prominent reason why Americans seek medical attention and extensive literature has identified the importance of the endocannabinoid pathway in controlling pain
-
Cannabis Use in Adolescence: A Review of Neuroimaging Findings. J. Dual Diagn. (IF 1.231) Pub Date : 2019-07-16 Yann Chye,Erynn Christensen,Murat Yücel
Objective: Shifting policies and widespread acceptance of cannabis for medical and/or recreational purposes have fueled worries of increased cannabis initiation and use in adolescents. In particular, the adolescent period is thought to be associated with an increased susceptibility to the potential harms of repeated cannabis use, due to being a critical period for neuromaturational events in the brain
-
Cannabis and Epilepsy. J. Dual Diagn. (IF 1.231) Pub Date : 2019-08-06 Alexander Doyle,Jay Harvey
Objective: In recent years, the use of cannabidiol in the treatment of refractory epilepsy has been increasingly investigated and has been gaining public support as a novel way to treat these disorders. Marijuana has been used for medical purposes for thousands of years, and a lot of research has been conducted over the last several decades into the chemistry and pharmacology of marijuana and its many
-
Exploring Cannabis and Alcohol Co-Use in Adolescents: A Narrative Review of the Evidence. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-13 Hollis C Karoly,J Megan Ross,Jarrod M Ellingson,Sarah W Feldstein Ewing
Objective: Amidst the evolving policy surrounding cannabis legalization in the United States, cannabis use is becoming increasingly prevalent as perceptions of harm decrease, particularly among adolescents. Cannabis and alcohol are commonly used by adolescents and are often used together. However, developmental research has historically taken a "single substance" approach to examine the association
-
Adverse Effects of Cannabis Use on Neurocognitive Functioning: A Systematic Review of Meta- Analytic Studies. J. Dual Diagn. (IF 1.231) Pub Date : 2019-06-22 Jacqueline C Duperrouzel,Karen Granja,Ileana Pacheco-Colón,Raul Gonzalez
Objective: As the perceived risk of cannabis use continues to decline among youths and access continues to increase, it has become more important to synthesize the rapidly growing literature on the effects of cannabis on neurocognition. Hundreds of studies examining associations between cannabis use and neurocognitive functioning have been published in recent decades. However, results often differ
-
Cannabis Use and the Risk for Psychosis and Affective Disorders. J. Dual Diagn. (IF 1.231) Pub Date : 2019-10-24 Lucia Sideli,Harriet Quigley,Caterina La Cascia,Robin M Murray
Objective: This review discusses the relationship between cannabis use and psychotic, bipolar, depressive, and anxiety disorders, as well as suicide. It summarizes epidemiological evidence from cross-sectional and long-term prospective studies and considers possible etiological mechanisms. Methods: Systematic reviews and methodologically robust studies in the field (from inception to February 2019)
-
Modeling the Comorbidity of Cannabis Abuse and Conduct Disorder/Conduct Problems from a Cognitive Neuroscience Perspective. J. Dual Diagn. (IF 1.231) Pub Date : 2019-10-14 R James Blair
Objective: A cognitive neuroscience perspective seeks to understand behavior, in this case the comorbidity of cannabis abuse and conduct disorder/conduct problems, in terms of dysfunction in cognitive processes underpinned by neural processes. The goal of this review is to articulate a cognitive neuroscience account of this comorbidity. Methods: Literature on the following issues will be reviewed:
-
Introduction to Cannabis Special Issue. J. Dual Diagn. (IF 1.231) Pub Date : 2020-01-06 Francesca M Filbey
(2020). Introduction to Cannabis Special Issue. Journal of Dual Diagnosis: Vol. 16, Cannabis, pp. 1-2.
-
Leveraging Nurses to Improve Care for Patients with Concurrent Disorders in Inpatient Mental Health Settings: A Scoping Review. J. Dual Diagn. (IF 1.231) Pub Date : 2020-04-22 Emma Garrod,Emily Jenkins,Leanne M Currie,Liza McGuinness,Kofi Bonnie
Objective: Several challenges have been identified for patients with concurrent disorders and the providers that care for them, contributing to a pressing need for interventions to improve outcomes, particularly within inpatient mental health settings. Methods: A systematic search of peer-reviewed literature was conducted using four online databases: CINAHL, MEDLINE (Ovid), PsycInfo and Web of Science
-
Trauma-informed Drug Screens for Veterans with Co-occurring Disorders: A Case Series. J. Dual Diagn. (IF 1.231) Pub Date : 2020-04-14 Arielle A J Scoglio,Jay A Gorman,Dongchan Park,Shehzad Jooma,Shane W Kraus
Objective: This case series describes and illustrates the effective use of a trauma-informed approach, GLAPE, to provide drug screens for individuals in substance use treatment programs. The GLAPE approach recognizes that individuals who have experienced traumatic events and are recovering from substance use difficulties may also face unique challenges when engaging in mental health treatment. The
-
Negative Affect Mediates the Association between Posttraumatic Cognitions and Craving in Veterans with Posttraumatic Stress Disorder and Alcohol Use Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2020-04-07 Robert Lyons,Moira Haller,Guadalupe Rivera,Sonya Norman
Objective: The co-occurrence of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD) is common. Individuals with PTSD/AUD commonly drink to cope with PTSD symptoms, which maintains PTSD/AUD, and may result in increased craving for alcohol. Negative affect is implicated in negative reinforcement models of craving. Further, Emotional Processing Theory posits that posttraumatic cognitions
-
Validation of Addiction Severity Index (ASI) for Assessment of Psychiatric Comorbidity in Multi-Site Randomized Controlled Trials. J. Dual Diagn. (IF 1.231) Pub Date : 2020-04-07 Ryoko Susukida,Ramin Mojtabai,Masoumeh Amin-Esmaeili
Objective: This study aimed to assess the validity of the psychiatric problems subscale of the Addiction Severity Index (ASI-psych) to ascertain psychiatric comorbidity among individuals participating in randomized controlled trials (RCTs) of substance use disorder (SUD) treatments. Methods: The ASI-psych score among 1,660 RCT participants of National Institute of Drug Abuse Clinical Trials Network
-
Depression and Outcomes of Methadone and Buprenorphine Treatment Among People with Opioid Use Disorders: A Literature Review. J. Dual Diagn. (IF 1.231) Pub Date : 2020-02-23 Maykel Farag Ghabrash,Arash Bahremand,Martine Veilleux,Geneviève Blais-Normandin,Gabrielle Chicoine,Catherine Sutra-Cole,Navdeep Kaur,Daniela Ziegler,Simon Dubreucq,Louis-Christophe Juteau,Laurent Lestage,Didier Jutras-Aswad
Objective: Depression is the most common psychiatric comorbidity among people with opioid use disorders (OUDs). However, whether and how comorbid depression is associated with the outcomes of opioid agonist therapy (OAT) remains poorly understood. The objective of this review was to identify and describe the association between depression and main outcomes (opioid use and treatment retention) of methadone
-
Methamphetamine Use and Antipsychotic-related Extrapyramidal Side-effects in Patients with Psychotic Disorders. J. Dual Diagn. (IF 1.231) Pub Date : 2020-01-26 Henk S Temmingh,Wim van den Brink,Fleur Howells,Goodman Sibeko,Dan J Stein
Objective: Extrapyramidal side-effects (EPSE) are frequent in patients treated with antipsychotics and comorbid substance use disorders (SUDs). Methamphetamine has been shown to act as a dopaminergic neurotoxin. We aimed to determine whether EPSE occur more often in patients with psychotic disorders and co-occurring methamphetamine (MA) use disorders, and we examined the relationship between MA use
-
Comorbidity Profiles of Psychotic Patients in Emergency Psychiatry. J. Dual Diagn. (IF 1.231) Pub Date : 2020-01-26 Tania Lecomte,Charles-Édouard Giguère,Briana Cloutier,Stéphane Potvin,
Objectives: Individuals with psychotic symptoms presenting to emergency psychiatry often have comorbid symptoms, such as substance misuse, depression, and anxiety. Many will also have symptoms linked to previous traumatic experiences such as impulsivity, often found in comorbid personality disorders. Although various studies have looked at specific comorbid symptoms, little is known regarding how these
-
Substance Use and Co-occurring Physical Health Problems: File Review of a Residential Drug and Alcohol Treatment Service. J. Dual Diagn. (IF 1.231) Pub Date : 2019-12-26 Briony Osborne,Peter J Kelly,Briony Larance,Laura D Robinson,Rowena Ivers,Frank P Deane,Adrian Webber,David Kelly
Objectives: Physical health conditions cause significant disability and mortality among people living with alcohol and other drug problems. There has been limited research on the prevalence of health problems among clinical samples of people with substance use disorders, particularly among those in residential treatment. Yet residential settings provide unique opportunity for responding to health needs
-
Associations between Medication Assisted Therapy Services Delivery and Mortality in a National Cohort of Veterans with Posttraumatic Stress Disorder and Opioid Use Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2019-12-18 Natalie B Riblet,Daniel J Gottlieb,Brian Shiner,Sarah L Cornelius,Bradley V Watts
Objective: Opioid use disorder (OUD) is a notable concern in the United States (US) and strongly associated with mortality. There is a high prevalence of OUD in patients with posttraumatic stress disorder (PTSD) and the mortality associated with OUD may be exacerbated in patients with PTSD. Medication-assisted treatment (MAT) for OUD has become standard of care for OUD and has been shown to reduce
-
Brain Gene Expression Profiling of Individuals With Dual Diagnosis Who Died by Suicide. J. Dual Diagn. (IF 1.231) Pub Date : 2019-11-27 Brenda Cabrera-Mendoza,Cristóbal Fresno,Nancy Monroy-Jaramillo,Gabriel Rodrigo Fries,Consuelo Walss-Bass,David C Glahn,Patricia Ostrosky-Wegman,Alma Delia Genis-Mendoza,José Jaime Martínez-Magaña,Ana Luisa Romero-Pimentel,Carlos Enrique Díaz-Otañez,Fernando García-Dolores,Eli Elier González-Sáenz,Roberto Cuauhtemoc Mendoza-Morales,Gonzalo Flores,Rubén Vázquez-Roque,Humberto Nicolini
Objective: Dual diagnosis (DD) is the co-occurrence of at least one substance use disorder and one or more mental disorders in a given individual. Despite this comorbidity being highly prevalent and associated with adverse clinical outcomes, its neurobiology remains unclear. Furthermore, patients with DD are at higher risk for suicidal behavior in comparison with single disorder patients. Our objective
-
Understanding Barriers and Facilitators to the Uptake of Best Practices for the Treatment of Co-Occurring Chronic Pain and Opioid Use Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2019-11-26 Allyson L Varley,Sara Lappan,Juliet Jackson,Burel R Goodin,Andrea L Cherrington,Heith Copes,Peter S Hendricks
Objective: Patients with a combination of chronic pain and opioid use disorder have unique needs and may present a challenge for clinicians and health care systems. The objective of the present study was to use qualitative methods to explore factors influencing the uptake of best practices for co-occurring chronic pain and opioid use disorder in order to inform a quantitative survey assessing primary
-
Predictive Outcome Validity of General Health Questionnaire (GHQ-28) in Substance Abuse Patients Treated in Therapeutic Communities. J. Dual Diagn. (IF 1.231) Pub Date : 2019-10-14 Esperanza Vergara-Moragues,Francisco González-Saiz
Objective: The use of psychoactive substances has been one of the most important global public health problems over the last few decades. Among the problems associated with substance use, dual diagnosis is one of the most relevant. This study aims to investigate the predictive validity of the GHQ-28 (General Health Questionnaire-28; "probable psychiatric cases") in relation to poor treatment outcome
-
Measuring Personality Problems in Patients With Substance Use Disorders: A Cross-Sample Validation. J. Dual Diagn. (IF 1.231) Pub Date : 2019-10-01 Espen Ajo Arnevik,Geir Pedersen,Espen Walderhaug,Ingebjørg Lien,Theresa Wilberg,Benjamin Hummelen
Objective: Co-occurrence of substance use disorder and personality disorder (PD) is associated with greater functional impairment and mutual deterioration of the prognosis. More information is needed about the extent of personality problems in substance use disorder patients and when these problems can be assessed in a reliable way. The aim of this study was to compare the levels and scale reliability
-
Patient Characteristics Predicting Abstinence in Substance Use Disorder Patients With Comorbid Mental Disorders. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-28 Lisanne J van Hagen,Marleen M de Waal,Carolien Christ,Jack J M Dekker,Anna E Goudriaan
Objective: Patients with both a substance use disorder and comorbid mental disorder, or dual diagnosis, form a heterogeneous group with complex treatment needs. Dual diagnosis patients have worse treatment outcomes compared to patients with substance use disorders alone. There is a lack of research focusing on predictors of treatment outcome in dual diagnosis patients. The aim of this study was to
-
Outcome of Patients With High Depressive Symptoms on Admission to Methadone Maintenance Treatment. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-17 Elad Malik,Miriam Adelson,Anat Sason,Shaul Schreiber,Einat Peles
Objective: Comorbidity of depression among individuals with opioid addiction is highly prevalent, but their outcome in methadone maintenance treatment (MMT) is not well determined. Methods: Characteristics and outcomes (retention until December 2017) of newly admitted and already (5.5 ± 4 years) in MMT patients with available Hamilton Depression Rating Scale (HAM-D) scores on admission were studied
-
Exploring the Relationships Between Eating Disorders and Mental Health in Women Attending Residential Substance Use Treatment. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-13 Laura D Robinson,Peter J Kelly,Frank P Deane,Samantha L Reis
Objective: Comorbid eating disorders (EDs) and ED symptoms are highly prevalent among women with substance use disorders and may be a barrier to recovery. Higher rates of psychiatric illness are common when more than one disorder is present. Yet little is known about the rates and risk factors for EDs/ED symptoms in women attending treatment centers in Australia. The primary aim is to examine the prevalence
-
Use of Prescribed Psychotropic Medications in an Opioid Substitution Therapy Cohort. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-13 Oliver Gale-Grant,James Bailey,Olivia Burke,Michael J Kelleher
Objective: Comorbid mental illness is extremely common in individuals receiving opioid substitution therapy. The use of common psychiatric medications is complex in this cohort with increased risks of drug–drug interaction, overdose, and diversion or abuse of prescribed medication. We have therefore investigated rates of co-prescribing and psychiatric comorbidity in a cohort of individuals receiving
-
Are Computer-Based Treatment Programs Effective at Reducing Symptoms of Substance Misuse and Mental Health Difficulties Within Adults? A Systematic Review. J. Dual Diagn. (IF 1.231) Pub Date : 2019-09-02 Stephanie Dugdale,Sarah Elison-Davies,Heather Semper,Jonathan Ward,Glyn Davies
Objective: Comorbid substance misuse and mental health difficulties are recognized as a leading contributor to disease burden worldwide. Amid cuts to health care services, computer-based interventions may provide support for patients experiencing these difficulties. The aims of this systematic review were to identify and investigate the efficacy of these computer-based interventions at improving substance
-
Public Perceptions of Recovery Prospects and Peer Style (Support and Confrontation) in Services for Serious Mental Illness Versus Substance Use Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2019-07-16 Patrick W Corrigan,Sang Qin,Larry Davidson,Georg Schomerus,Valery Shuman,David Smelson
Objective: Peer services have been identified as a key agent in promoting recovery (both as an outcome and as a process) for people with co-occurring disorders. We attempt to make sense of this connection here by examining public perceptions of recovery and peer services separately for serious mental illness (SMI) and substance use disorder. Two different styles may guide peers in providing SMI or
-
PTSD Symptom Clusters and Craving Differs by Primary Drug of Choice. J. Dual Diagn. (IF 1.231) Pub Date : 2019-07-14 Vanessa C Somohano,Kristoffer L Rehder,Tyree Dingle,Taylor Shank,Sarah Bowen
Objective: Research has demonstrated a cyclical relationship between posttraumatic stress disorder (PTSD) and substance use disorder. Identifying factors that link PTSD symptom clusters and substance use disorder may illuminate mechanisms underlying the PTSD–substance use disorder relationship, better informing interventions that target this comorbidity. The current study of individuals enrolled in
-
Sensorimotor Gating in Cocaine-Related Disorder with Comorbid Schizophrenia or Antisocial Personality Disorder. J. Dual Diagn. (IF 1.231) Pub Date : 2019-07-09 Alejandro Fuertes-Saiz,Ana Benito,César Mateu,Sonia Carratalá,Isabel Almodóvar,Abel Baquero,Gonzalo Haro
Objective: Schizophrenia, cocaine-related disorder, antisocial personality disorder, and psychopathy share biological bases, but few studies discriminate between these disorders by means of prepulse inhibition. This work studies the phenotype of patients with cocaine-related disorders who are vulnerable to presenting a dual diagnosis of schizophrenia or antisocial personality disorder, by evaluating
-
Impact of Substance Use and Mental Health Comorbidity on Health Care Access in Canada. J. Dual Diagn. (IF 1.231) Pub Date : 2019-07-07 Grace J Đào,Caroline Brunelle,David Speed
Objective: Psychological disorders and substance use comorbidity is associated with greater symptomatology and a worse prognosis. Previous research has highlighted discrepancies in the level of use of health care services in individuals experiencing comorbidity compared to those with mental disorders or substance use disorders alone. The purpose of the current study was to compare mental health service
-
Health Care Processes Contributing to Suicide Risk in Veterans During and After Residential Substance Abuse Treatment. J. Dual Diagn. (IF 1.231) Pub Date : 2019-06-28 Natalie B Riblet,Lauren Kenneally,Brian Shiner,Bradley V Watts
Objective: Substance use disorders are an important risk factor for suicide. While residential drug treatment programs improve clinical outcomes for substance use disorders, less is known about the role of related health care processes in contributing to suicide risk. These data may help to inform strategies to prevent suicide during and after residential treatment. Methods: A retrospective analysis
-
Electronic Cigarette Use During a Randomized Trial of Interventions for Smoking Cessation Among Medicaid Beneficiaries with Mental Illness. J. Dual Diagn. (IF 1.231) Pub Date : 2019-06-06 Cynthia L Bianco,Sarah I Pratt,Joelle C Ferron,Mary F Brunette
Objective: People with mental illness have high rates of cigarette smoking, but many wish to quit. Electronic cigarette (e-cigarette) use has become increasingly common, especially among smokers who wish to quit, but research on whether this facilitates quitting has been mixed, and little research has examined e-cigarette use among smokers with mental illness. This secondary analysis examined the associations
-
Comorbidity of Physical Disorders Among Patients With Severe Mental Illness With and Without Substance Use Disorders: A Systematic Review and Meta-Analysis. J. Dual Diagn. (IF 1.231) Pub Date : 2019-06-04 Ifeoma N Onyeka,Margrethe Collier Høegh,Eldbjørg Marie Nåheim Eien,Bright I Nwaru,Ingrid Melle
Objective: Physical disorders in patients with severe mental illness (SMI) are common and they tend to be underdiagnosed by clinicians, which might lead to negative treatment outcomes. The presence of substance use disorders could further aggravate the situation. There are existing systematic reviews on physical disorders among individuals with SMI in general but none of these previous reviews stratified